"Your contribution to advancing life-changing medications is crucial. You not only have the opportunity to reap the benefits of safer more effective medicines for your own health, but also for the health of your family and generations to come. Receive Compensation for your Time and Travel. No Insurance Required. Participate in research and share your experience with others"

During the past decade, Ventavia Research Group, LLC conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 18 clinical trials were completed, i.e. on average, 48.6% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 18 clinical trials were completed. i.e. 81.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ventavia Research Group, LLC" #1 sponsor was "Pfizer" with 15 trials, followed by "BioNTech SE" with 4 trials sponsored, "Abbott Nutrition" with 3 trials sponsored, "Allergan" with 2 trials sponsored and "Bavarian Nordic" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ventavia Research Group, LLC" #1 collaborator was "Pfizer" with 4 trials as a collaborator, "Alder Biopharmaceuticals, Inc." with 1 trials as a collaborator, "IQVIA Inc." with 1 trials as a collaborator and "OSTAtistics" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Ventavia Research Group, LLC" are "Migraine" (4 trials), "COVID-19" (3 trials), "Episodic Migraine" (3 trials), "Migraine, With or Without Aura" (3 trials) and "Respiratory Tract Infection" (3 trials). Many other conditions were trialed in "Ventavia Research Group, LLC" in a lesser frequency.

Most popular intervention types in "Ventavia Research Group, LLC" are "Biological" (19 trials), "Drug" (14 trials), "Other" (9 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (23 trials), "Rimegepant" (5 trials), "BNT162b2" (3 trials), "Atogepant" (2 trials) and "Control Infant Formula" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ventavia Research Group, LLC" are 32 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Ventavia Research Group, LLC". undefined are not yet recruiting, 2 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Ventavia Research Group, LLC, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Ventavia Research Group, LLC, 1 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".